Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Algernon Pharmaceuticalsinc (AGN.CN)

Algernon Pharmaceuticalsinc (AGN.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,028
  • Shares Outstanding, K 1,675
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,734 K
  • 60-Month Beta -1.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.42
Trade AGN.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -2.82
  • Most Recent Earnings -1.10 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.000 +34.75%
on 05/02/22
6.000 -10.17%
on 04/19/22
-0.540 (-9.11%)
since 04/13/22
3-Month
4.000 +34.75%
on 05/02/22
6.770 -20.38%
on 02/14/22
-1.400 (-20.62%)
since 02/11/22
52-Week
3.250 +65.85%
on 12/06/21
18.000 -70.06%
on 06/07/21
-9.610 (-64.07%)
since 05/13/21

Most Recent Stories

More News
The Power Play by The Market Herald Releases New Interviews With Algernon Pharmaceuticals, Adastra Holdings and C3 Metals

VANCOUVER, BC / ACCESSWIRE/ February 23, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Algernon Pharmaceuticals, Adastra Holdings and C3 Metals on their latest...

AGN.CN : 5.390 (+12.76%)
XTRX.CN : 0.650 (-4.41%)
CCCM.VN : 0.080 (-11.11%)
Algernon Pharmaceuticals Begins Manufacturing of Repirinast and Launches New Chronic Kidney Disease Research Program

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO)...

AGN.CN : 5.390 (+12.76%)
AGNPF : 4.0300 (+5.22%)
Algernon Pharmaceuticals Announces Completion of Enrollment in its Phase 2 Study of Ifenprodil for IPF and Chronic Cough

VANCOUVER, British Columbia, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO)...

AGN.CN : 5.390 (+12.76%)
AGNPF : 4.0300 (+5.22%)
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent Application for Idiopathic Pulmonary Fibrosis

VANCOUVER, British Columbia, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW)...

AGNPF : 4.0300 (+5.22%)
AGN.CN : 5.390 (+12.76%)
AGNPD : 3.2600 (-5.51%)
The Power Play by The Market Herald Releases Interviews with Algernon Pharmaceuticals, Newrange Gold, and Fokus Mining

VANCOUVER, BC / ACCESSWIRE / January 24, 2022 / The Power Play by The Market Herald has announced the release of a new interviews with Algernon Pharmaceuticals, Newrange Gold, and Fokus Mining discussing...

AGN.CN : 5.390 (+12.76%)
NRG.VN : 0.065 (+8.33%)
FKM.VN : 0.065 (unch)
Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual Property

VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO)...

AGN.CN : 5.390 (+12.76%)
AGNPF : 4.0300 (+5.22%)
The Power Play by The Market Herald Releases Interviews With Xali Gold, Falcon Gold, Psyched Wellness, Argentina Lithium, and Algernon Pharmaceuticals

VANCOUVER, BC / ACCESSWIRE / January 19, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Xali Gold, Falcon Gold, Psyched Wellness, Argentina Lithium, and Algernon...

XGC.VN : 0.075 (+7.14%)
FG.VN : 0.090 (+5.88%)
PSYC.CN : 0.105 (unch)
LIT.VN : 0.320 (unch)
AGN.CN : 5.390 (+12.76%)
Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study

VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)...

AGN.CN : 5.390 (+12.76%)
AGNPF : 4.0300 (+5.22%)
The Power Play by The Market Herald Releases Interview with EarthRenew, Algernon Pharmaceuticals and Rockwell Medical

VANCOUVER, BC / ACCESSWIRE / January 14, 2022 / The Power Play by The Market Herald has announced the release of new interviews with EarthRenew, Algernon Pharmaceuticals and Rockwell Medical discussing...

ERTH.CN : 0.295 (+3.51%)
AGN.CN : 5.390 (+12.76%)
RMTI : 2.02 (-14.90%)
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 2b Ifenprodil Chronic Cough Study

VANCOUVER, British Columbia, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)...

AGN.CN : 5.390 (+12.76%)
AGNPF : 4.0300 (+5.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 5.630
2nd Resistance Point 5.510
1st Resistance Point 5.450
Last Price 5.390
1st Support Level 5.270
2nd Support Level 5.150
3rd Support Level 5.090

See More

52-Week High 18.000
Fibonacci 61.8% 12.365
Fibonacci 50% 10.625
Fibonacci 38.2% 8.884
Last Price 5.390
52-Week Low 3.250

See More

Business Summary

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar